Biopsy-naive with strong clinical suspicion of PCa: PSMA PET-CT has high sensitivity, specificity and negative likelihood ratio for detecting prostate carcinoma in biopsy-naive patients with clinical and biochemical findings indicative of PCa and complementary mpMRI. This evidence concerns the gene FOLH1 and prostate carcinoma.